Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01012115 · ClinicalTrials.gov registry record
Coagulation Factors, Cytokines and Tissue Injury Markers in Sepsis
A clinical trial of Sepsis, sponsored by University of Oklahoma.
- Completed
- Registry status
- 500
- Enrollment target
- 2
- Study locations
NCT01012115: Completed study of Sepsis, sponsored by University of Oklahoma.
NCT01012115 is a study of Sepsis that has completed, run by University of Oklahoma. The registered enrollment target is 500 participants, below the 6,559-participant average among 90 other Sepsis trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01012115, a study of Sepsis, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
In an effort to better understand the interaction between the different mediators, the investigators propose to examine the time course of mediators, the indexes of organ injury and the coagulation cascade.
Conditions Studied
Study Locations (2)
Oklahoma
- OU Medical Center - Oklahoma City
- Veterans Affairs Medical Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-09 |
What the finished NCT01012115 record still lists
NCT01012115 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 6,559-participant average among 90 other Sepsis trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Sepsis appearing as the primary indexed condition, and to 0 interventions.
NCT01012115 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT01012115 about?
NCT01012115 is a clinical study titled "Coagulation Factors, Cytokines and Tissue Injury Markers in Sepsis". In an effort to better understand the interaction between the different mediators, the investigators propose to examine the time course of mediators, the indexes of organ injury and the coagulation cascade.
What is the current status of trial NCT01012115?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2009-10. Estimated completion is 2011-09.
What conditions does trial NCT01012115 study?
This clinical trial studies the following conditions: Sepsis.
Who is sponsoring clinical trial NCT01012115?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01012115 being conducted?
This trial has 2 study locations across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01012115's enrollment target sits among peer trials
500 23rd of 90 higher than 66 of 90 other Sepsis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sepsis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia